IT response to first therapeutic approach in 56 treated patients
| . | All patients (n = 56) . | Response to therapy . | |||
|---|---|---|---|---|---|
| CR (n = 21) . | PR (n = 12) . | MR (n = 5) . | NR (n = 18) . | ||
| Chemotherapy plus steroids* | 18 | 9 | 5 | 3 | 1 |
| Chemotherapy | 4 | 2 | 0 | 0 | 2 |
| Splenectomy | 1 | 1 | 0 | 0 | 0 |
| Steroids | 12 | 3 | 4 | 0 | 5 |
| IVIg | 8 | 1 | 2 | 0 | 5 |
| IVIg plus steroids | 13 | 5 | 1 | 2 | 5 |
| . | All patients (n = 56) . | Response to therapy . | |||
|---|---|---|---|---|---|
| CR (n = 21) . | PR (n = 12) . | MR (n = 5) . | NR (n = 18) . | ||
| Chemotherapy plus steroids* | 18 | 9 | 5 | 3 | 1 |
| Chemotherapy | 4 | 2 | 0 | 0 | 2 |
| Splenectomy | 1 | 1 | 0 | 0 | 0 |
| Steroids | 12 | 3 | 4 | 0 | 5 |
| IVIg | 8 | 1 | 2 | 0 | 5 |
| IVIg plus steroids | 13 | 5 | 1 | 2 | 5 |
Data are numbers of patients. Chemotherapy includes Chlorembucil alone, COP, and CVP.
Includes one patient treated with rituximab who obtained CR.